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In Escherichia coli, signal recognition particle (SRP)-
dependent targeting of inner membrane proteins has
been described. In vitro cross-linking studies have dem-
onstrated that short nascent chains exposing a highly
hydrophobic targeting signal interact with the SRP.
This SRP, assisted by its receptor, FtsY, mediates the
transfer to a common translocation site in the inner
membrane that contains SecA, SecG, and SecY. Here we
describe a further in vitro reconstitution of SRP-medi-
ated membrane insertion in which purified ribosome-
nascent chain-SRP complexes are targeted to the puri-
fied SecYEG complex contained in proteoliposomes in a
process that requires the SRP-receptor FtsY and GTP.
We found that in this system SecA and ATP are dispen-
sable for both the transfer of the nascent inner mem-
brane protein FtsQ to SecY and its stable membrane
insertion. Release of the SRP from nascent FtsQ also
occurred in the absence of SecYEG complex indicating a
functional interaction of FtsY with lipids. These data
suggest that SRP/FtsY and SecB/SecA constitute distinct
targeting routes.
Going across or integrating into the inner membrane pre-
sents two different challenges to proteins synthesized in the
cytosol of a prokaryotic cell, and this is reflected by the exist-
ence of two main targeting routes. The SecB pathway is spe-
cialized for the targeting of periplasmic and outer membrane
proteins. SecB is a cytosolic chaperone that binds to the mature
region of a subset of preproteins (1). The SecB-preprotein com-
plex is targeted to SecA, which is bound with high affinity to
the membrane-embedded SecYEG complex (for review, see Ref.
2).
Both in vivo and in vitro experiments indicate that the signal
recognition particle (SRP)1 pathway is primarily used for the
targeting of integral inner membrane proteins (3–7). This path-
way resembles SRP-mediated targeting of proteins to the mem-
brane of the endoplasmic reticulum (ER) in eukaryotes (for
review, see Ref. 8). The eukaryotic SRP interacts with nascent
membrane and secreted proteins and targets them to the SRP
receptor SRa at the ER membrane. The eukaryotic SRP is a
complex consisting of six proteins arranged on an RNA scaffold,
the 7 S RNA. Escherichia coli contains a smaller SRP composed
of the P48 protein and the 4.5 S RNA, which are homologous to
the eukaryotic SRP54 and the 7 S RNA, respectively (for re-
view, see Refs. 9 and 10). In addition, an SRa homologue has
been identified in E. coli, designated FtsY (7, 11). Both P48 and
FtsY (and their eukaryotic counterparts) are GTPases, and
GTP binding and hydrolysis regulate the targeting cycle in a
mechanism that has not yet been fully defined (12–14). In vivo
overproduction of polytopic inner membrane proteins titrated
out the limited amount of endogenous E. coli SRP (5), whereas
depletion of essential SRP components affected membrane tar-
geting of both polytopic and bitopic inner membrane proteins
(3, 4).
We have developed an in vitro cross-linking approach to
dissect subsequent stages in SRP-mediated protein targeting.
Short nascent inner membrane proteins synthesized in a mem-
brane-free E. coli cell extract were shown to interact with the
SRP via their amino-terminal hydrophobic targeting signal (6).
The SRP receptor FtsY, GTP, and inverted E. coli inner mem-
brane vesicles were shown to be required for release of the SRP
from the nascent chain (7). Upon release of the SRP at the
membrane, the nascent chain inserts into the membrane in the
vicinity of the translocase components SecA, SecY, and SecG
(7). Hence, it seems that the SecB- and SRP-targeting path-
ways converge at a common membrane translocation complex.
The exact composition of the translocase that is reached by the
different routes may differ and has not yet been determined. Of
particular interest is the cross-linking of SRP-targeted precur-
sors to SecA, which functions as the molecular motor for trans-
location in the SecB pathway (2).
In an attempt to further define the minimal requirements for
SRP-mediated targeting and membrane insertion, we have
used proteoliposomes instead of inner membrane vesicles in
our targeting assay. Short nascent chains of the inner mem-
brane protein FtsQ were efficiently targeted to the E. coli
SecYEG complex reconstituted in E. coli phospholipids. Hence,
SecA seems dispensable for SRP-mediated protein targeting to
the E. coli translocase. Before stable membrane insertion, the
SRP was efficiently released from the nascent chains by FtsY in
a GTP-dependent reaction. Protein-free liposomes also induced
significant FtsY-mediated release of the SRP from the nascent
chains indicating that the interaction of FtsY with lipids is
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sufficient to induce a conformational change in the SRP that
lowers its affinity for the nascent chains.
EXPERIMENTAL PROCEDURES
Materials—Restriction enzymes were from Roche Molecular Bio-
chemicals GmbH (Mannheim, Germany). Megashortscript T7 tran-
scription kit was from Ambion Inc. (Austin, TX). [35S]Methionine and
protein A-Sepharose were from Amersham Pharmacia Biotech (Buck-
inghamshire, UK). Disuccinimidyl suberate (DSS) was from Pierce. E.
coli total phospholipid extract was from Avanti Polar Lipids Inc. (Pel-
ham, AL). Aurintricarboxylic acid was from ICN Biomedicals Inc. (Au-
rora, OH). Nucleotides and all other chemicals were supplied by Sigma.
Strains and Plasmid Constructs—Strain MC4100 was used to obtain
translation lysate and inverted membrane vesicles (INVs) (15). Strain
Top10F9 was used as host for plasmid pC4Meth108FtsQ (6), and the
OmpT and OmpP protease-deficient strain SF100 was used as expres-
sion host for plasmid pET349 to allow the overexpression of SecYEG
(16).
In Vitro Transcription and Translation, Formation of SRNC Com-
plexes—pC4Meth108FtsQ plasmid was linearized with HindIII and
transcribed using T7 polymerase. The resulting truncated mRNAs were
translated for 20 min at 25 °C in an S-135 E. coli in vitro translation
system to produce ribosome nascent chain complexes (RNCs) (6). After
3 min of incubation, aurintricarboxylic acid (1 mM) was added to inhibit
further initiation of translation resulting in homogeneous nascent
chain length. Translation was stopped by adding 3 mM chlorampheni-
col. To allow SRP-RNC (SRNC) complex formation, 260 nM reconsti-
tuted SRP was added to the translation reaction (7). After 5 min of
incubation at 25 °C, samples were chilled on ice, and the resulting
SRNC complexes were purified from the translation mixture by centrif-
ugation through a high salt sucrose cushion (17) and resuspended in RN
buffer (100 mM KOAc, 5 mM Mg(OAc)2, 50 mM Hepes-KOH, pH 7.9).
Purification of the Translocase and Its Reconstitution into Proteoli-
posomes—The E. coli SecYEG complex that carries a hexahistidine tag
at the amino terminus of SecY was purified and reconstituted in ace-
tone/ether-washed E. coli phospholipids as described (16). Standard
proteoliposomes were obtained by the reconstitution of 200 ml of
SecYEG (50 mg/ml) in 40 ml of lipids (20 mg/ml). Proteoliposomes used
in the experiment described in Fig. 3 were prepared using different
amounts of 0.2 mg/ml SecYEG (0–50 ml) diluted in a total volume of 200
ml of purification buffer (1.25% (w/v octylglucoside, 0.3 mg/ml phospho-
lipids, 40% (w/v) glycerol, and 50 mM KCl in Tris-HCl, pH 7.8). These
amounts of SecYEG were reconstituted with 40 ml of phospholipids,
yielding (v/v) ratios of 0–1.25. Before use, proteoliposomes were soni-
cated 3 times for 10 s; E. coli SecA was purified as described (18).
Targeting and Cross-linking—Targeting reactions were done as de-
scribed previously by incubating purified SRNCs together with 1 mM
FtsY, 50 mM GTP, 50 mM ATP, and either INVs (1.25 mg/ml protein) or
proteoliposomes for 5 min at 25 °C (7). Modifications to this standard
reaction protocol are described in the figure legends. Cross-linking was
induced with 1 mM DSS for 10 min at 25 °C and quenched at 4 °C by
adding one-tenth volume of quenching buffer (1 M glycine, 100 mM
NaHCO3, pH 8.5). To separate integral membrane from soluble and
peripheral cross-linked complexes, samples were treated with 0.18 M
Na2CO3, pH 11.3, for 15 min on ice. The membrane fractions containing
integral membrane proteins were pelleted by ultracentrifugation (10
min, 110,000 3 g) and resuspended in RN buffer. Supernatant fractions
were trichloroacetic acid-precipitated, washed with cold acetone, and
resuspended in RN buffer. Samples were immunoprecipitated as de-
scribed (19) or mixed directly with 23 SDS-gel loading buffer before gel
electrophoresis.
Immunodepletion of SecA from Translation Lysate—Anti-SecA se-
rum was added to protein A-Sepharose slurry and incubated for 1 h at
room temperature. After incubation the Sepharose was washed twice
with incubation buffer (30 mM Tris-HCL pH 7.5, 150 mM NaCl, 30 mM
Tris-HCL pH 7.5) and once with lysate buffer (10 mM triethylammo-
nium, 10 mM Mg(OAc)2, 22 mM N(CH3)4Ac). To prepare a control lysate,
protein A-Sepharose was prepared in the same way except that no
anti-SecA serum was added. Both Sepharose preparations were col-
lected by centrifugation and resuspended in MC4100 translation lysate.
After 2 h of incubation at 4 °C, the Sepharose beads were spun down
and the supernatants recovered. Supernatant corresponding to the
incubation with anti-SecA-loaded Sepharose was referred to as SecA2
lysate, and supernatant corresponding to the incubation with Sepha-
rose only was referred to as SecA1 lysate. Both lysates were analyzed by
immunoblotting using anti-SecA serum to verify the extent of depletion.
Sample Analysis and Quantification—Samples were analyzed on 12,
15, or 4–15% gradient SDS-polyacrylamide gels. Radiolabeled proteins
were visualized by phosphor imaging using a Molecular Dynamics
PhosphorImager 473 and quantified using the Imagequant software
from Molecular Dynamics.
RESULTS
Nascent FtsQ Is Efficiently Targeted to the Translocase Con-
tained in Proteoliposomes—FtsQ is a type II E. coli inner mem-
brane protein, which was used as a model protein for SRP-
mediated targeting throughout this study. An in vitro SRP-
dependent targeting assay was developed in which short FtsQ
RNCs were efficiently targeted to the translocase contained in
purified INVs. Interaction of the labeled nascent chain with
SecY and SecA was demonstrated by formation of covalent
bonds using the bifunctional cross-linker reagent DSS (7). In
this study we further investigated this SRP-dependent target-
ing process. To define the essential membrane components
required for targeting and membrane insertion, proteolipo-
somes composed of E. coli phospholipids and purified SecYEG
complex were used instead of INVs.
Short (108-mer) FtsQ nascent chains were produced in vitro
using a membrane-free E. coli translation lysate. Under these
conditions the endogenous SRP contained in the lysate is ti-
trated out by the preponderance of exposed hydrophobic tar-
geting signals. SRP loading efficiency was increased by adding
reconstituted E. coli SRP after the translation reaction (7). The
resulting SRP-RNCs complexes (SRNCs) were purified through
a high salt sucrose cushion and incubated in the presence of
FtsY, the E. coli homologue of the eukaryotic SRP receptor SRa
(9) and GTP, which were shown to be essential for their proper
targeting to the membranes and for efficient release of the SRP
from the nascent chain (7). As accepting membranes, we com-
pared INVs and proteoliposomes. Each reaction contained
equal amounts of SecY as judged by quantitative immunoblot-
ting (data not shown). After the targeting reaction cross-link-
ing of 108FtsQ was induced using the membrane-permeable
bifunctional cross-linker DSS and the membranes were ex-
tracted with Na2CO3 to separate membrane integral from sol-
uble and membrane peripheral cross-linked complexes.
Either with INVs or with proteoliposomes, a 108FtsQ cross-
linking adduct appeared at about 50 kDa in the Na2CO3 pellet
(Fig. 1, lanes 3 and 5, respectively). This complex represents a
membrane integral complex of the radiolabeled 108FtsQ and
SecY, as demonstrated by immunoprecipitation (Fig. 1, lanes 7
and 11). The SecY adduct, which originates from the proteoli-
posomes, migrates slightly slower than the SecY from the INVs
due to the histidine extension that is attached to the purified
SecY used to reconstitute the SecYEG complex in the proteoli-
posomes (16). In addition, 108FtsQ was also found to be cross-
linked to the other membrane integral components of the trans-
locase, SecE and SecG (Fig. 1, lanes 8 and 9 for INVs, lanes 12
and 13 for proteoliposomes). High molecular weight (;69 kDa)
cross-linked complexes in the Na2CO3 pellet of both INVs and
proteoliposomes were also immunoprecipitated with antibodies
directed against SecE (Fig. 1, lanes 8 and 12) and SecG (Fig. 1,
lanes 9 and 13). These complexes probably represent trimeric
structures consisting of 108FtsQ, SecY, and either SecE or
SecG (7).
As previously reported (7), cross-linking to SecA (;120 kDa
product) is detected in the Na2CO3 pellet samples when INVs
are used in the targeting reaction (Fig. 1, lanes 3 and 7). A
cross-linking adduct of ;220 kDa is also immunoprecipitated
from the Na2CO3 pellet with anti-SecA serum and might cor-
respond to cross-linked SecA dimer (Fig. 1, lanes 3 and 7). Upon
immunoprecipitation a weak SecA adduct is also detected in
the Na2CO3 pellet from proteoliposomes (Fig. 1, lane 10). Be-
cause the proteoliposomes do not contain any SecA initially, we
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assume that some SecA contained in the translation lysate is
co-purified with the SRNCs and is incorporated into the pro-
teoliposomes during the targeting reaction. This point will be
addressed in the last paragraph under “Results.”
In the Na2CO3 supernatant from the INVs adducts to the
SRP component P48 and trigger factor were detected (Fig. 1,
lanes 15, 19, and 20) as observed before (7). Trigger factor may
act as a general folding catalyst via its prolyl isomerase activity
and was shown to interact with all nascent chains regardless of
their hydrophobicity (6). In contrast, hardly any P48 adduct
could be detected in the Na2CO3 supernatant when proteolipo-
somes were used as target membranes, whereas cross-linking
to trigger factor was relatively efficient (Fig. 1, lanes 17, 22,
and 23). This suggests an efficient release of the SRP from the
FtsQ RNCs followed by an efficient targeting to the translocase
as indicated by the strong cross-linking signal to SecY in the
Na2CO3 pellet samples.
From these data we conclude that proteoliposomes composed
of E. coli phospholipids and purified SecYEG complex support
the transfer of 108FtsQ in a reconstituted SRP-mediated tar-
geting assay from the SRP to the translocase. Compared with
targeting reactions that contain INVs, the release of the SRP
and the association with the translocase is even more efficient
when proteoliposomes are used.
Targeting to the Translocase Contained in Proteoliposomes
Only Requires FtsY and GTP Binding—SRP-mediated target-
ing of nascent FtsQ to SecY in the INVs requires FtsY and GTP
or its nonhydrolyzable analogue GMP-PNP (7). We investi-
gated whether release of the SRP from nascent FtsQ and as-
sociation with SecY in the proteoliposomes occurs via the same
mechanism by studying its dependence on FtsY and nucleo-
tides in the targeting assay described above. As shown in Fig.
2, the release of the SRP and the association with SecY did not
occur in the absence of FtsY (Fig. 2, lanes 9, 10, and 11).
Proteoliposomes in combination with FtsY were essential for
the release of the SRP (Fig. 2, lanes 2 and 4). GTP or GMP-PNP
(lanes 5 and 7) but not AMP-PNP or GDP (lanes 6 and 8)
supported the transfer reaction. Consistently, mutant FtsY,
FtsY A449 (13) that is unable to bind GTP, was not functional
in the targeting assay (data not shown).
Based on these results, we conclude that targeting of nascent
FtsQ to proteoliposomes mechanistically resembles the target-
ing to INVs and thus provides a valid and attractive model for
detailed studies on the mechanism of nascent chain transfer
and membrane insertion.
Liposomes and FtsY Are Sufficient to Induce the Dissociation
of SRP-RNCs Complexes—In vivo, FtsY is equally distributed
between the cytosol and inner membrane (11). We have ob-
tained evidence that FtsY has affinity for lipids (20).2 To study
the influence of the protein:lipid ratio on the efficiency of nas-
cent chain transfer, proteoliposomes of different composition
were prepared and tested in our targeting assay in the presence
of FtsY and GMP-PNP. The efficiency of 108FtsQ targeting was
monitored by quantifying the P48 cross-linking adducts in the
Na2CO3 supernatant and the SecY cross-linking adducts in the
Na2CO3 pellets (Fig. 3). As expected, the strongest cross-link-
ing to P48 was observed when membranes were omitted in the
targeting reaction and this signal was taken as 100%. Different
proteoliposomes were made by mixing a fixed amount of E. coli
phospholipids with increasing amounts of purified SecYEG
complex. The targeting efficiency correlated with the SecYEG
concentration in the lipid bilayer (Fig. 3). Proteoliposomes con-
taining a SecYEG:lipid ratio of 1.25 resulted in the most effi-
cient targeting as indicated by the weakest cross-linking to P48
and the strongest cross-linking to SecY.
Surprisingly, when liposomes that do not contain any
SecYEG complex were used in the targeting reaction a signif-
icant SRP release was observed (;53%, Fig. 3). This release
was completely dependent on the addition of both FtsY and
GTP or GMP-PNP (not shown). Apparently, the interaction of
FtsY with the lipids is sufficient to induce significant GTP-de-
pendent release of the SRP from the nascent chain. However,
this SRP release is not followed by effective membrane inser-
tion of the 108FtsQ as judged by Na2CO3 extraction (data not
shown). Apparently, the SecYEG complex is necessary and
sufficient to obtain a stable integration into the lipid bilayer.
SecA Is Not Required for the SRP-dependent Targeting and
Membrane Insertion of 108FtsQ RNCs—SecA is a peripheral
translocase component that plays a key role in the post-trans-
lational translocation process by functioning as a receptor for
precursor proteins and as an ATP-driven molecular motor (2).
In a previous study (7), we demonstrated that 108FtsQ RNCs
targeted to INVs were in close contact not only to the “core”
translocase component SecY but also to SecA (see also Fig. 1,
lanes 3 and 6). It remained unclear whether SecA plays an
active role in the observed SRP-mediated targeting and mem-
brane insertion of 108FtsQ or whether the SecA cross-linking
adducts were obtained just because SecA is located in the
vicinity of the nascent chain as a structural subunit of the E.
coli translocase (2). If this last hypothesis is correct, SecA
should be dispensable in the SRP-dependent targeting reac-
tion. This could be tested by using SecYEG proteoliposomes as
SecA-free target membranes. However, as shown in Fig. 1 (lane
10) weak cross-linking of SecA to 108FtsQ was observed in the
Na2CO3 pellet of proteoliposomes. Apparently, SecA is co-puri-
fied with the SRNC preparation and can be incorporated into
proteoliposomes during the targeting reaction. The affinity of
SecA for SecY and for acidic phospholipids might underlie this
2 E. de. Leeuw, K. te Kaat, C. Moser, G. Menestrina, R. Demel, B.
de Kruijff, J. Luirink, and I. Sinning, manuscript submitted.
FIG. 1. 108FtsQ RNCs are efficiently targeted to proteolipo-
somes. 108FtsQ RNCs were incubated with 260 nM reconstituted SRP.
The SRNC complexes thus formed were purified by sedimentation
through a high salt sucrose cushion and used for targeting as described
under “Experimental Procedures.” Either INVs or proteoliposomes
(Prot) containing SecYEG complex were added to the targeting reaction
that contained 1 mM FtsY. After cross-linking with DSS, soluble and
peripheral membrane cross-linked complexes were extracted with
Na2CO3. Both Na2CO3 pellet samples and trichloroacetic acid-precipi-
tated Na2CO3 supernatant samples were examined by immunoprecipi-
tation (IP) using the indicated antisera. Relevant cross-linking products
are indicated with an arrow.
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transfer of SecA from the SRNCs to the proteoliposomes (2). We
estimated by Western blotting that about 0.3% of the SecA
present in the translation lysate co-purifies with the SRNCs
upon sedimentation of the ribosomes through a high salt su-
crose cushion (data not shown). Two observations suggest that
it is most likely that SecA is co-purified via its general affinity
for ribosomes (21), rather than via a direct interaction with the
FtsQ nascent chains. First, SecA was never found cross-linked
to nascent FtsQ or any other nascent polypeptide in the ab-
sence of membranes even when added in excess (6). Second,
when translation reactions were either not supplemented with
any mRNA or supplemented with truncated mRNA encoding
nascent chains of a cytosolic protein, the same amount of SecA
was co-purified with the ribosomal fraction (data not shown).
To remove this residual SecA, we immunodepleted the trans-
lation lysate using anti-SecA serum (see “Experimental Proce-
dures” for details). After this procedure no SecA could be de-
tected by immunoblotting in the translation lysate (SecA2
lysate) compared with a mock treated lysate (SecA1 lysate)
(data not shown). Both lysates remained active for translation.
108FtsQ RNCs were produced using either SecA2 or SecA1
lysate and loaded with reconstituted SRP. After purification
the two kinds of SRNCs were used in different targeting reac-
tions to which purified SecA was added (0, 0.1, and 0.5 mM, final
concentrations). Interaction with proteoliposomes was assessed
by DSS-induced cross-linking to SecY (Fig. 4, A–C) and by
quantification of the resistance of the RNCs to Na2CO3 extrac-
tion (Fig. 4D). When a SecA2 lysate was used for translation
and when no additional SecA was added to the targeting reac-
tion, cross-linking to SecY was observed (Fig. 4A, lane 4) and
the 108FtsQ was inserted into the membrane in a Na2CO3
resistant conformation (Fig. 4D). Thus, the FtsQ RNCs are able
to reach the translocase and become inserted into the mem-
brane in the absence of SecA. Upon addition of SecA to the
targeting reaction cross-linking to SecY in the Na2CO3 pellet
was slightly reduced irrespective of the translation lysate used,
whereas SecA cross-linking adducts (**) appeared (Fig. 4A,
lanes 1–6 and Fig. 4B). Part of the SecA adducts were extracted
by Na2CO3 (Fig. 4A, lanes 7–12). For both translation lysates,
addition of purified SecA to the targeting reaction slightly
reduced the Na2CO3 resistance of the targeted RNCs (Fig. 4D)
consistent with the decrease in cross-linking to SecY.
To confirm that the different cross-linking adducts observed
were indeed related to either SecA or to SecY, immunoprecipi-
tations were carried out after cross-linking. The SecA1 lysate
was used to generate the RNCs, and 0.5 mM SecA was added to
the targeting reaction. In the Na2CO3 pellet sample the 50-kDa
product (*) was indeed immunoprecipitated with anti-SecY se-
rum (Fig. 4C, lane 3). Both the major 120-kDa cross-linking
adducts (**) and minor 220-kDa products present in the
Na2CO3 pellet and supernatant were immunoprecipitated with
the anti-SecA serum (Fig. 4C, lane 2). We assume that the
;220-kDa product corresponds to cross-linked complexes be-
tween the RNCs and the dimeric form of SecA. The SecA
related adducts of ;150 and ;45 kDa ( ) in the Na2CO3 pellet
are most likely proteolytic fragments of the SecA dimer and
monomer cross-linking products.
From these data, we conclude that SecA is not required for
efficient targeting and initial membrane insertion of FtsQ nas-
cent chains in vitro. Furthermore, at high SecA concentrations
there is a weak competition effect between SecA and SecY for
the binding of RNCs delivered to the membrane via the SRP
pathway. This competition seems to reduce the 108FtsQ inser-
tion into the membrane.
DISCUSSION
We have further developed our homologous in vitro targeting
assay that supports SRP-mediated targeting and membrane
insertion of nascent E. coli inner membrane proteins (7). The
assay now contains purified 108FtsQ RNCs saturated with
SRP, FtsY, GTP, and proteoliposomes that consist of purified
E. coli phospholipids and the core translocon complex SecYEG.
In this system, the SRP was released from the nascent chain in
a GTP-dependent reaction, associated with SecY and acquired
a Na2CO3-resistant conformation in the proteoliposomes as
efficiently as in crude INVs. Thus, we have defined the minimal
requirements for an efficient in vitro SRP-dependent targeting
to the core components of the E. coli translocon. Preliminary
experiments on the topology of targeted 108FtsQ in both INVs
and proteoliposomes using cysteine replacement coupled to
chemical labeling, suggest that it has the same topology as the
native protein (data not shown). No additional proteinaceous
membrane factors are required in these early steps of the
targeting process. Notably, the SecDF/YajC subcomplex is dis-
pensable, and may therefore be specifically devoted for the
FIG. 2. GTP binding is required for
the release of SRP from 108FtsQ
SRNCs and for the concomitant in-
teraction of 108FtsQ with SecY con-
tained in the SecYEG proteolipo-
somes. Different nucleotides (50 mM each)
were used in the targeting assay (see the
legend to Fig. 1) that either contained or
did not contain proteoliposomes. Cross-
linking adducts to P48 (X-P48) in the
Na2CO3 supernatant fractions and to
SecY (X-SecY) in the Na2CO3 pellet frac-
tions are shown.
FIG. 3. Effect of the SecYEG:lipid ratio on SRP-mediated tar-
geting to proteoliposomes. 108FtsQ SRNCs were incubated in pres-
ence of FtsY (1 mM) and GMP-PNP (50 mM). INVs or proteoliposomes of
different composition were used in the targeting reaction (see the leg-
end to Fig. 1). The ratios between phospholipids (fixed volume) and
purified SecYEG used to reconstitute proteoliposomes are given. In the
Na2CO3 supernatant fractions, the strongest cross-linking to P48 (X-
P48) was taken as 100%. In the Na2CO3 pellet fractions, the strongest
cross-linking to SecY (X-SecY) was taken as 100%.
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translocation or the membrane insertion of preproteins deliv-
ered via the SecB-dependent pathway (2).
Apparently, for the initial insertion of the inner membrane
protein FtsQ, SecA, and ATP are not required. However, as
judged by protein cross-linking, SecA was in close proximity to
nascent FtsQ targeted to INVs (7) or when proteoliposomes
were supplemented with SecA (this study). Probably, SecA is
juxtaposed to the nascent chain due to its affinity for SecY (22,
23) rather than playing a crucial role in the initial insertion
process or in the transfer of the nascent chain to SecY. As
suggested by this study, when present in excess, SecA actually
interfered with the transfer to SecY. Interestingly, a point
mutation in SecY has been reported that specifically impaired
the integration of integral membrane proteins but not the
secretion of SecB-targeted precursors. In this conditional
strain, expression of SecA was up-regulated (24).
SecA may be involved at a later stage in the insertion of inner
membrane proteins especially when large periplasmic domains
are translocated. The role of SecA in the complete assembly of
inner membrane proteins is difficult to study in vivo and may
differ for different substrate proteins (25–27). It should be noted
that full-length FtsQ did not integrate into SecYEG proteolipo-
somes either in the presence or absence of SecA (data not shown)
suggesting that additional components are required for complete
in vitro reconstitution of inner membrane protein biogenesis.
Interestingly, liposomes that consist solely of E. coli phos-
pholipids are still able to support the FtsY-mediated release of
the SRP from the nascent chain, albeit less efficiently than
SecYEG containing proteoliposomes. We have previously dem-
onstrated that FtsY is able to associate with RNC-SRP com-
plexes in the absence of GTP and membranes (7). INVs and
GTP-binding but not hydrolysis were required to dissociate the
SRP from the nascent chain (7). Apparently, FtsY pilots the
targeting complex to the lipids without the requirement of any
specific membrane receptor. This might cause a conformational
change that is transferred to P48 in the SRP thus increasing
the affinity of both P48 and FtsY for GTP. By analogy with the
eukaryotic SRP cycle, binding of GTP to P48 may reduce its
affinity for the nascent chain (28, 29). The nascent chain that is
released at the membrane does not insert stably into the lipid
bilayer in an alkali resistant conformation but requires the
SecYEG complex to acquire a stable membrane association.
FtsY is located in part in the cytosol and in part in the
cytoplasmic membrane (11). It is a highly charged protein that
does not contain any predicted membrane spanning segments
and its mechanism of association with the membrane is obscure
(20). The data presented in this study indicate that in contrast
to its mammalian counterpart SRa, FtsY can function in the
release of the SRP in the absence of a dedicated membrane
anchoring protein. This might explain the ability of FtsY to
FIG. 4. SecA is not required for the SRP-dependent targeting of nascent 108FtsQ to SecY and membrane insertion. A SecA2 lysate
was prepared by immunodepletion and used to produce 108FtsQ RNCs in a comparison with mock-treated control (SecA1) lysate. SRNCs were
prepared as described in the legend to Fig. 1. The targeting reactions containing SRNCs, 1 mM FtsY, 50 mM ATP, 50 mM GTP, and proteoliposomes
were supplemented or not with additional SecA (0, 0.1, or 0.5 mM, final concentrations). A, after cross-linking with DSS and carbonate extraction,
Na2CO3 pellet samples (p) and trichloroacetic acid-precipitated Na2CO3 supernatant samples (s) were examined by SDS-polyacrylamide gel
electrophoresis. Positions of the relevant cross-linked complexes, X-SecY (*) and X-SecA (**), are indicated. B, cross-linking adducts observed in
Na2CO3 pellet samples in panel A were quantified by phosphor imaging. For each product the total Imagequant units measured are given (0 mM
SecA, 0; 0.1 mM SecA, s; 0.5 mM SecA, u). C, the same targeting reaction was done as in panel A using SecA1 lysate for translation and 0.5 mM extra
SecA in the targeting reaction. After cross-linking with DSS and Na2CO3 extraction, the cross-linked complexes present in the Na2CO3 pellet
fraction (Pel.) and in the trichloroacetic acid-precipitated Na2CO3 supernatant fraction (Sup.) were immunoprecipitated (IP) with the indicated
antisera. D, the same experiment was done as described in the legend to panel A except that no DSS treatment was carried out before the Na2CO3
extraction. The targeting reactions were supplemented or not with purified SecA (0 mM SecA, 0; 0.1 mM SecA, s; 0.5 mM SecA, u). The percentage
of RNCs remaining associated with the membrane pellets after Na2CO3 extraction was determined by SDS-polyacrylamide gel electrophoresis and
phosphor imaging.
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cooperate with E. coli SRP in the targeting of proteins to
microsomal membranes in a heterologous in vitro targeting
assay (30). Consistent with this suggestion, we have recently
observed that FtsY interacts with lipids using a phospholipid
monolayer technique.2 Through its affinity for lipids, FtsY may
increase the effective concentration of SRNCs at the membrane
(30). Still, proteoliposomes function more efficiently in the re-
lease of the SRP, which may be related to additional targeting
functions of the ribosome and SRP. It is well established that
eukaryotic ribosomes have affinity for Sec61p, the protein con-
ducting channel in the ER membrane (31). Alternatively FtsY,
in addition to its association with lipids, may interact directly
with the SecYEG complex. However, an association of this kind
could not be detected by cross-linking, immunoprecipitation or
co-purification approaches.3
The reconstituted targeting system described in this study
will be invaluable for a detailed analysis of the consecutive
steps during SRP-mediated protein targeting and membrane
insertion, allowing the intermolecular interactions, dynamics,
and energy requirements of this process to be studied. The
assay will also provide a means to identify soluble and mem-
brane components specifically devoted to the proper assembly
and folding of inner membrane proteins. Ultimately, this ap-
proach should lead to the full reconstitution of inner membrane
protein biosynthesis.
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